Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Rubinsztein

Showing results (41-50 of 312) with videos related to

Pageof 32
Sort By:
Trends in Genetics : TIG|April 25, 2003
Transcriptional abnormalities in Huntington diseaseKatharine L Sugars, David C Rubinsztein
Autophagy|April 28, 2011
Regulation of autophagy by lysosomal positioningViktor I Korolchuk, David C Rubinsztein
Autophagy|December 16, 2010
The Parkinson disease protein α-synuclein inhibits autophagyAshley R Winslow, David C Rubinsztein
Nature Reviews. Molecular Cell Biology|August 6, 2024
Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseasesRalph A Nixon, David C Rubinsztein
Cerebellum (London, England)|April 18, 2008
Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategiesBenjamin R Underwood, David C Rubinsztein
Human Molecular Genetics|January 5, 2011
Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophyJanet E Davies, David C Rubinsztein
Experimental Neurology|April 25, 2006
Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragmentsDavid C Rubinsztein, James A Huntington
Autophagy|January 19, 2010
Broadening the therapeutic scope for rapamycin treatmentFiona M Menzies, David C Rubinsztein
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 2, 2016
Diminishing return for mechanistic therapeutics with neurodegenerative disease duration?: There may be a point in the course of a neurodegenerative condition where therapeutics targeting disease-causing mechanisms are futileDavid C Rubinsztein, Harry T Orr
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2025
Monitoring Autophagosome Biogenesis and Degradation in Mammalian Cells Using LC3B BlottingJennifer E Palmer, David C Rubinsztein
Pageof 32

Showing results (41-50 of 312) with videos related to

Sort By:
Pageof 32
Trends in Genetics : TIG|April 25, 2003
Transcriptional abnormalities in Huntington diseaseKatharine L Sugars, David C Rubinsztein
Autophagy|April 28, 2011
Regulation of autophagy by lysosomal positioningViktor I Korolchuk, David C Rubinsztein
Autophagy|December 16, 2010
The Parkinson disease protein α-synuclein inhibits autophagyAshley R Winslow, David C Rubinsztein
Nature Reviews. Molecular Cell Biology|August 6, 2024
Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseasesRalph A Nixon, David C Rubinsztein
Cerebellum (London, England)|April 18, 2008
Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategiesBenjamin R Underwood, David C Rubinsztein
Human Molecular Genetics|January 5, 2011
Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophyJanet E Davies, David C Rubinsztein
Experimental Neurology|April 25, 2006
Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragmentsDavid C Rubinsztein, James A Huntington
Autophagy|January 19, 2010
Broadening the therapeutic scope for rapamycin treatmentFiona M Menzies, David C Rubinsztein
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 2, 2016
Diminishing return for mechanistic therapeutics with neurodegenerative disease duration?: There may be a point in the course of a neurodegenerative condition where therapeutics targeting disease-causing mechanisms are futileDavid C Rubinsztein, Harry T Orr
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2025
Monitoring Autophagosome Biogenesis and Degradation in Mammalian Cells Using LC3B BlottingJennifer E Palmer, David C Rubinsztein
Pageof 32